Uemura, Motohide
Nakaigawa, Noboru
Sassa, Naoto
Tatsugami, Katsunori
Harada, Kenichi
Yamasaki, Toshinari
Matsubara, Nobuaki
Yoshimoto, Takuya
Nakagawa, Yuki
Fukuyama, Tamaki
Oya, Mototsugu
Shinohara, Nobuo
Uemura, Hirotsugu http://orcid.org/0000-0002-3665-9523
Tsuzuki, Toyonori
Funding for this research was provided by:
Chugai Pharmaceutical
Article History
Received: 4 February 2021
Accepted: 12 July 2021
First Online: 21 July 2021
Change Date: 27 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10147-021-02008-5
Declarations
:
: Fukuyama T, Nakagawa Y, and Yoshimoto T are employees of Chugai Pharmaceutical. All honoraria received by the following authors were outside of the submitted work: Uemura H (Pfizer, MSD, Janssen, BMS, Ono Pharmaceutical, Astellas Pharma, and Bayer), Tsuzuki T (Novartis, Chugai Pharmaceutical, AstraZeneca, Janssen, BMS, Ono Pharmaceutical, Nippon Kayaku, Astellas Pharma, Bayer, Takeda, and Daiichi Sankyo), Oya M (Pfizer, Novartis, AstraZeneca, Janssen, BMS, Ono Pharmaceutical, Astellas Pharma, Bayer, Takeda, and Sanofi), Shinohara N (Pfizer, Novartis, Janssen, BMS, Ono Pharmaceutical, Astellas Pharma, Takeda, and Sanofi).